Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paliperidone ER Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia: a Randomized, Open-label, Controlled Trial

NCT00827840 is registered in ClinicalTrials.gov with Chonnam National University Hospital as lead sponsor.

NCT NCT00827840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00827840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paliperidone ER Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia: a Randomized, Open-label, Controlled Trial
Lead sponsor
Chonnam National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2008
Completion date
February 28, 2011
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia